Cargando…
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519452/ https://www.ncbi.nlm.nih.gov/pubmed/36050473 http://dx.doi.org/10.1038/s41586-022-05287-8 |
| _version_ | 1784799402378919936 |
|---|---|
| author | Zingg, Daniel Bhin, Jinhyuk Yemelyanenko, Julia Kas, Sjors M. Rolfs, Frank Lutz, Catrin Lee, Jessica K. Klarenbeek, Sjoerd Silverman, Ian M. Annunziato, Stefano Chan, Chang S. Piersma, Sander R. Eijkman, Timo Badoux, Madelon Gogola, Ewa Siteur, Bjørn Sprengers, Justin de Klein, Bim de Goeij-de Haas, Richard R. Riedlinger, Gregory M. Ke, Hua Madison, Russell Drenth, Anne Paulien van der Burg, Eline Schut, Eva Henneman, Linda van Miltenburg, Martine H. Proost, Natalie Zhen, Huiling Wientjens, Ellen de Bruijn, Roebi de Ruiter, Julian R. Boon, Ute de Korte-Grimmerink, Renske van Gerwen, Bastiaan Féliz, Luis Abou-Alfa, Ghassan K. Ross, Jeffrey S. van de Ven, Marieke Rottenberg, Sven Cuppen, Edwin Chessex, Anne Vaslin Ali, Siraj M. Burn, Timothy C. Jimenez, Connie R. Ganesan, Shridar Wessels, Lodewyk F. A. Jonkers, Jos |
| author_facet | Zingg, Daniel Bhin, Jinhyuk Yemelyanenko, Julia Kas, Sjors M. Rolfs, Frank Lutz, Catrin Lee, Jessica K. Klarenbeek, Sjoerd Silverman, Ian M. Annunziato, Stefano Chan, Chang S. Piersma, Sander R. Eijkman, Timo Badoux, Madelon Gogola, Ewa Siteur, Bjørn Sprengers, Justin de Klein, Bim de Goeij-de Haas, Richard R. Riedlinger, Gregory M. Ke, Hua Madison, Russell Drenth, Anne Paulien van der Burg, Eline Schut, Eva Henneman, Linda van Miltenburg, Martine H. Proost, Natalie Zhen, Huiling Wientjens, Ellen de Bruijn, Roebi de Ruiter, Julian R. Boon, Ute de Korte-Grimmerink, Renske van Gerwen, Bastiaan Féliz, Luis Abou-Alfa, Ghassan K. Ross, Jeffrey S. van de Ven, Marieke Rottenberg, Sven Cuppen, Edwin Chessex, Anne Vaslin Ali, Siraj M. Burn, Timothy C. Jimenez, Connie R. Ganesan, Shridar Wessels, Lodewyk F. A. Jonkers, Jos |
| author_sort | Zingg, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9519452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95194522022-09-30 Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers Zingg, Daniel Bhin, Jinhyuk Yemelyanenko, Julia Kas, Sjors M. Rolfs, Frank Lutz, Catrin Lee, Jessica K. Klarenbeek, Sjoerd Silverman, Ian M. Annunziato, Stefano Chan, Chang S. Piersma, Sander R. Eijkman, Timo Badoux, Madelon Gogola, Ewa Siteur, Bjørn Sprengers, Justin de Klein, Bim de Goeij-de Haas, Richard R. Riedlinger, Gregory M. Ke, Hua Madison, Russell Drenth, Anne Paulien van der Burg, Eline Schut, Eva Henneman, Linda van Miltenburg, Martine H. Proost, Natalie Zhen, Huiling Wientjens, Ellen de Bruijn, Roebi de Ruiter, Julian R. Boon, Ute de Korte-Grimmerink, Renske van Gerwen, Bastiaan Féliz, Luis Abou-Alfa, Ghassan K. Ross, Jeffrey S. van de Ven, Marieke Rottenberg, Sven Cuppen, Edwin Chessex, Anne Vaslin Ali, Siraj M. Burn, Timothy C. Jimenez, Connie R. Ganesan, Shridar Wessels, Lodewyk F. A. Jonkers, Jos Nature Publisher Correction Nature Publishing Group UK 2022-09-01 2022 /pmc/articles/PMC9519452/ /pubmed/36050473 http://dx.doi.org/10.1038/s41586-022-05287-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Publisher Correction Zingg, Daniel Bhin, Jinhyuk Yemelyanenko, Julia Kas, Sjors M. Rolfs, Frank Lutz, Catrin Lee, Jessica K. Klarenbeek, Sjoerd Silverman, Ian M. Annunziato, Stefano Chan, Chang S. Piersma, Sander R. Eijkman, Timo Badoux, Madelon Gogola, Ewa Siteur, Bjørn Sprengers, Justin de Klein, Bim de Goeij-de Haas, Richard R. Riedlinger, Gregory M. Ke, Hua Madison, Russell Drenth, Anne Paulien van der Burg, Eline Schut, Eva Henneman, Linda van Miltenburg, Martine H. Proost, Natalie Zhen, Huiling Wientjens, Ellen de Bruijn, Roebi de Ruiter, Julian R. Boon, Ute de Korte-Grimmerink, Renske van Gerwen, Bastiaan Féliz, Luis Abou-Alfa, Ghassan K. Ross, Jeffrey S. van de Ven, Marieke Rottenberg, Sven Cuppen, Edwin Chessex, Anne Vaslin Ali, Siraj M. Burn, Timothy C. Jimenez, Connie R. Ganesan, Shridar Wessels, Lodewyk F. A. Jonkers, Jos Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers |
| title | Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers |
| title_full | Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers |
| title_fullStr | Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers |
| title_full_unstemmed | Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers |
| title_short | Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers |
| title_sort | publisher correction: truncated fgfr2 is a clinically actionable oncogene in multiple cancers |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519452/ https://www.ncbi.nlm.nih.gov/pubmed/36050473 http://dx.doi.org/10.1038/s41586-022-05287-8 |
| work_keys_str_mv | AT zinggdaniel publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT bhinjinhyuk publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT yemelyanenkojulia publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT kassjorsm publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT rolfsfrank publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT lutzcatrin publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT leejessicak publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT klarenbeeksjoerd publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT silvermanianm publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT annunziatostefano publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT chanchangs publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT piersmasanderr publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT eijkmantimo publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT badouxmadelon publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT gogolaewa publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT siteurbjørn publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT sprengersjustin publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT dekleinbim publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT degoeijdehaasrichardr publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT riedlingergregorym publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT kehua publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT madisonrussell publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT drenthannepaulien publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT vanderburgeline publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT schuteva publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT hennemanlinda publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT vanmiltenburgmartineh publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT proostnatalie publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT zhenhuiling publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT wientjensellen publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT debruijnroebi publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT deruiterjulianr publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT boonute publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT dekortegrimmerinkrenske publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT vangerwenbastiaan publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT felizluis publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT aboualfaghassank publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT rossjeffreys publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT vandevenmarieke publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT rottenbergsven publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT cuppenedwin publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT chessexannevaslin publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT alisirajm publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT burntimothyc publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT jimenezconnier publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT ganesanshridar publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT wesselslodewykfa publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers AT jonkersjos publishercorrectiontruncatedfgfr2isaclinicallyactionableoncogeneinmultiplecancers |